行情

CPHI

CPHI

中国医药控股
AMEX

实时行情|Nasdaq Last Sale

0.4869
-0.0150
-2.99%
已收盘, 17:52 08/04 EDT
开盘
0.4900
昨收
0.5019
最高
0.5045
最低
0.4820
成交量
39.83万
成交额
--
52周最高
1.400
52周最低
0.2121
市值
2,121.89万
市盈率(TTM)
-1.0131
分时
5日
1月
3月
1年
5年

CPHI 新闻

更多
Edited Transcript of CPHI earnings conference call or presentation 15-May-20 12:30pm GMT
Thomson Reuters StreetEvents · 06/05 00:59
China Pharma Holdings, Inc. Reports First Quarter 2020 Financial Results
PR Newswire · 05/15 11:30
China Pharma Holding Q1 EPS $(0.020) Down From $(0.010) YoY, Sales $1.800M Down From $2.929M YoY
China Pharma Holding (AMEX:CPHI) reported quarterly losses of $(0.020) per share. This is a 100 percent decrease over losses of $(0.010) per share from the same period last year. The company reported $1.800 million in
Benzinga · 05/15 10:33
36 Stocks Moving in Thursday's Pre-Market Session
Gainers Genius Brands International, Inc. (NASDAQ: GNUS) shares rose 150% to $1.20 in pre-market trading after climbing 49% on Wednesday.
Benzinga · 05/07 11:15
China Pharmaceutical Holdings Co., Ltd. Added Mask Production Lines
PR Newswire · 04/15 13:00
Updates - China Pharma Holdings, Inc. Reports Fiscal Year 2019 Financial Results
PR Newswire · 04/14 21:30
How Much is China Pharma Holdings, Inc.'s (NYSEMKT:CPHI) CEO Getting Paid?
Simply Wall St. · 04/14 12:10
Edited Transcript of CPHI earnings conference call or presentation 31-Mar-20 12:30pm GMT
Thomson Reuters StreetEvents · 04/05 00:57

所属板块

生物技术和医学研究
+0.02%
制药与医学研究
-0.36%

热门股票

代码
价格
涨跌幅

CPHI 简况

China Pharma Holdings, Inc. is a holding company. The Company conducts its production, marketing, finance, development and administrative activities through its subsidiary, Hainan Helpson Medical & Biotechnology Co., Ltd. (Helpson) in the People's Republic of China (PRC). It is engaged in the development, manufacture and marketing of pharmaceutical products for human use in connection with various diseases and medical conditions in the PRC. It manufactures pharmaceutical products in the form of dry powder injectables, liquid injectables, tablets, capsules, oral solutions and granules. Its pharmaceutical products are sold on a prescription basis and are approved by the China Food and Drug Administration (the CFDA). The Company manufactured over 20 pharmaceutical products for various diseases and medical indications. It offers products for Central Nervous System (CNS) and Cerebral-Cardiovascular Diseases, Anti-infection and Respiratory Diseases, Digestive Diseases and Others.
展开

微牛提供China Pharma Holdings, Inc.(AMEX-CPHI)的股票价格,实时市场报价,专业分析师评级,深度图表和免费的CPHI股票新闻,以帮助您做出投资决策。

模拟交易:模拟炒股免费实操交易技能。您可用虚拟资金在真实市场环境中零成本、零风险体验交易CPHI股票基本功能。